View Author
scopus: 51261186200

Janssen, R.G.J.H.

(Rob Janssen)


ace inhibitors inhibitor polymorphism patient genotype study antagonist i antagonists antihypertensive angiotensin antihypertensive drugs interaction agtr 1 enzyme effect infarction system index date disease hypertension control index reference ischaemic heart disease pharmacy records diabetes mellitus dosage 1166c association risk reduction 1.0 netherland 1166c polymorphism treatment ace inhibitor utrecht 4656c renin table renin –angiotensin system van duijn cm ace t 3892c hypertensive allele pharmacy maastricht department blood pressure stroke cc genotype record reduction angiotensin i pharmacogenetic health subject university hypertensive patients 1 ddd antiplatelet drugs diabetes variation mellitu research result activity level therapy response blood participant hyperten kroon aa angiotensinogen heart utrecht institute ii antagonists factor receptor institute




1 Most Recent Publications

Genetic variation in the renin-angiotensin system, use of renin-angiotensin system inhibitors and the risk of myocardial infarction (Article)
Maitland-van der Zee, A-H. Wieren-de Wijer, D.B.M.A. van Klungel, O.H. Boer, A. de Kroon, A.A. Leeuw, P.W. de Schiffers, P. Janssen, R.G.J.H. Psaty, B.M. Tikka-Kleemola, P. Stricker, B.H.Ch.
2011-09-01